For Investors
Stock Quote
TSE Prime : 4004
- Last
- Change
-
2024.01.04
Management / IR
Resonac Aims to Establish a Corporate System to Continue Developing Best Products in the World
-CEO Takahashi gives new year message commemorating the first anniversary of the launch of Resonac- -
2023.11.21
Management / IR
Resonac Nominates Candidate for Outside Board Director
—Resonac Holdings nominates Dr. Kenji Yasukawa, Chairman of the Board, Astellas Pharma Inc., which is a global pharmaceutical company, as a candidate for Outside Board Director, aiming to strengthen the Resonac Group’s management capability and promote innovation— -
2023.11.21
Management / IR
Changes in Representative Director and Other Members of Management
